Fairmount Healthcare Fund II GP, Director of Viridian Therapeutics, Inc.\DE VRDN, has filed 4 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $30M. The latest trade was on 05/11.

FG

FG

Fairmount Healthcare Fund II GP

Director

Company

Viridian Therapeutics, Inc.\DE VRDN

First filing

23/11/01

Trades

13 trades

Buys / sales

4 / 0

12-month net buying

$30M

Last trade

05/11

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Viridian Therapeutics, Inc.\DEVRDN	Open-market buy	05/11	05/13	1,176,470 sh	$17.00	$19,999,990	+30.1%
Viridian Therapeutics, Inc.\DEVRDN	Open-market buy	25/10/23	25/10/27	454,545 sh	$22.00	$9,999,990	+13.1%
Viridian Therapeutics, Inc.\DEVRDN	Open-market buy	24/09/13	24/09/17	1,600,000 sh	$18.75	$30,000,000	+86.7%
Viridian Therapeutics, Inc.\DEVRDN	Open-market buy	24/01/22	24/01/24	476,190 sh	$21.00	$9,999,990	+34.9%